These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31661160)

  • 1. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
    Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
    Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
    Khan M; Siddiqi R; Naqvi K
    Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
    Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
    Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
    Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
    Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
    Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
    Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
    Porwit A; Béné MC
    Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.
    Munker R; Brazauskas R; Wang HL; de Lima M; Khoury HJ; Gale RP; Maziarz RT; Sandmaier BM; Weisdorf D; Saber W;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1024-1029. PubMed ID: 26903380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
    Cernan M; Szotkowski T; Pikalova Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):234-241. PubMed ID: 28422191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
    Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
    Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population-based study.
    Zając-Spychała O; Irga-Jaworska N; Drożyńska E; Muszyńska-Rosłan K; Krawczuk-Rybak M; Zawitkowska J; Kowalczyk J; Ćwiklińska M; Balwierz W; Mizia-Malarz A; Badowska W; Kamieńska E; Urasiński T; Kaczorowska A; Kazanowska B; Chybicka A; Wysocki M; Sędek Ł; Szczepański T; Woszczyk M; Matysiak M; Młynarski W; Karolczyk G; Chaber R; Wachowiak J
    Eur J Haematol; 2020 Jul; 105(1):85-93. PubMed ID: 32223036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
    Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.
    Maruffi M; Sposto R; Oberley MJ; Kysh L; Orgel E
    Leukemia; 2018 Jul; 32(7):1515-1528. PubMed ID: 29550836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
    Hrusak O; de Haas V; Stancikova J; Vakrmanova B; Janotova I; Mejstrikova E; Capek V; Trka J; Zaliova M; Luks A; Bleckmann K; Möricke A; Irving J; Konatkowska B; Alexander TB; Inaba H; Schmiegelow K; Stokley S; Zemanova Z; Moorman AV; Rossi JG; Felice MS; Dalla-Pozza L; Morales J; Dworzak M; Buldini B; Basso G; Campbell M; Cabrera ME; Marinov N; Elitzur S; Izraeli S; Luria D; Feuerstein T; Kolenova A; Svec P; Kreminska O; Rabin KR; Polychronopoulou S; da Costa E; Marquart HV; Kattamis A; Ratei R; Reinhardt D; Choi JK; Schrappe M; Stary J
    Blood; 2018 Jul; 132(3):264-276. PubMed ID: 29720486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases.
    Takahashi Y; Kaimi Y; Taniguchi H; Ochi T; Makino H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K; Maeshima AM
    Hum Pathol; 2024 Aug; 150():78-85. PubMed ID: 38945375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.
    Oberley MJ; Raikar SS; Wertheim GB; Malvar J; Sposto R; Rabin KR; Punia JN; Seif AE; Cahen VC; Schore RJ; Luca DC; Guinipero T; Woods WG; O'Gorman MRG; Orgel E
    Leukemia; 2020 Jul; 34(7):1741-1750. PubMed ID: 32060402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone.
    Tian H; Xu Y; Liu L; Yan L; Jin Z; Tang X; Han Y; Fu Z; Qiu H; Sun A; Wu D
    Leuk Res; 2016 Jun; 45():40-6. PubMed ID: 27088964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
    Rai V; Brahmbhatt B; Saha A; Thayakaran IP
    Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.